Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This is the first comparison of efficacy of Betaseron and Copaxone for treatment of relapsing forms of MS.
Epistemonikos ID: ba67337f8dafe59ca293e525f4fbaa7bcd9e8451
First added on: Aug 18, 2014